|
10088
|
Weisairuiji Biovac-A Mevac-A
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Approved
|
Biogenetech Co. Ltd., Zhejiang Pukang Biotechnology Co. Ltd.
|
2010
|
Thailand
|
1.5 years and above
|
Single dose
|
Subcutaneous
|
NA
|
H2 strain of HAV
|
H2-attenuated strain of HAV cultured in human diploid cells.
|
China FDA, US FDA
|
NA
|
NA
|
MEVAC-A
|
24280971
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130259/
|
https://apps.who.int/iris/bitstream/handle/10665/326501/97892516327-eng.pdf
|
|
10089
|
Weisairuiji Biovac-A Mevac-A
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Approved
|
Institute of Medical Biology, Chinese Academy of Medical Sciences
|
NA
|
China
|
NA
|
Single dose
|
Subcutaneous
|
NA
|
H2 strain of HAV
|
NA
|
China FDA, US FDA
|
NA
|
NA
|
NA
|
29661808
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
|
https://www.fda.moph.go.th/sites/drug/Shared%20Documents/Vaccine/U1DR1C1072530000811C-SPC.pdf
|
|
10090
|
HAVAC
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Approved
|
Changchun Institute of Biological Products
|
NA
|
China
|
NA
|
Single dose
|
Subcutaneous
|
NA
|
LA-1
|
NA
|
Government of Canada
|
Changchun Changsheng Life Sciences
|
NA
|
NA
|
24280971
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130259/
|
https://www.canada.ca/en/public-health/services/publications/healthy-living/update-recommended-use-hepatitis-b-vaccine.html
|
|
10091
|
HAVAC
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Approved
|
Changchun Institute of Biological Products
|
NA
|
China
|
NA
|
Single dose
|
Subcutaneous
|
NA
|
LA-1
|
NA
|
Government of Canada
|
Changchun Changsheng Life Sciences
|
NA
|
NA
|
29661808
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
|
https://www.canada.ca/en/public-health/services/publications/healthy-living/update-recommended-use-hepatitis-b-vaccine.html
|
|
10092
|
HAVRIX
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
GlaxoSmithKline
|
NA
|
Belgium
|
NA
|
P: 720 EU; Adults: 1440 EU; 2 doses 0, 6–12
|
Intramuscular
|
Aluminum (aluminium hydroxide)
|
HM-175
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
29661808
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
|
https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Package-Insert---HAVRIX.pdf
|
|
10093
|
VAQTA
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Merck & Co. Inc.
|
NA
|
USA
|
NA
|
P: 25 U; Adults: 50 U; 2 doses 0, 6–18
|
Intramuscular
|
Aluminum (aluminium hydroxide)
|
CR-326
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
29661808
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/vaqta
|
|
10094
|
AVAXIM
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
NA
|
Lyon, France
|
NA
|
P: 80 U; Adults: 160 U
|
Intramuscular
|
Aluminum (aluminium hydroxide)
|
GBM
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
29661808
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
|
https://www.fda.moph.go.th/sites/drug/Shared%20Documents/Vaccine/U1DR1C1062460010911C-SPC.pdf
|
|
10095
|
Healive
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sinovac Biotech Ltd.
|
NA
|
China
|
NA
|
P: 250 U; Adults: 500 U
|
Intramuscular
|
Aluminum (aluminium hydroxide)
|
TZ-84
|
NA
|
China FDA
|
NA
|
NA
|
NA
|
29661808
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
|
http://www.sinovac.com/news/shownews.php?id=764&lang=en
|
|
10096
|
Weisairuiji Biovac-A Mevac-A
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Institute of Medical Biology, Chinese Academy of Medical Sciences
|
NA
|
China
|
NA
|
P: 320 EU; Adults: 640 EU
|
Intramuscular
|
Aluminum (aluminium hydroxide)
|
Lv-8
|
NA
|
China FDA
|
NA
|
NA
|
NA
|
29661808
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482852/
|
|
10097
|
Veraxim
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Shanghai Wilson Bioengineering
|
NA
|
China
|
NA
|
P: 800 EU; Adults: 1600 EU
|
Intramuscular
|
Aluminum (aluminium hydroxide)
|
YN-5
|
NA
|
Government of China
|
NA
|
NA
|
NA
|
29661808
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
|
|
10098
|
HAVRIX
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
GlaxoSmithKline
|
NA
|
Belgium
|
12 months and above
|
Single dose for adult and 2 doses 6 to 12 months apart for infants
|
Intramuscular
|
NA
|
NA
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/hepatitis/hav/havfaq.htm#vaccine
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/havrix
|
|
10099
|
VAQTA
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Merck & Co. Inc.
|
NA
|
USA
|
12 months and above
|
2 doses 6 to 18 months apart
|
Intramuscular
|
NA
|
NA
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/hepatitis/hav/havfaq.htm#vaccine
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/vaqta
|
|
10366
|
EPAXAL
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Phase 3
|
Crucell, Berna Biotech
|
NA
|
Berne, Switzerland
|
NA
|
P: 24 U; Adults: 24 U
|
Intramuscular
|
NA
|
RG-SB
|
NA
|
NA
|
NA
|
NA
|
NA
|
29661808
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
|
NA
|
|
10367
|
Aimugen
|
Hepatitis A
|
Hepatitic
|
Hepatitis A virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Phase 3
|
Chemo-Sero-Therapeutic Research Institute
|
NA
|
Japan
|
NA
|
P: 0.5 µg; Adults: 0.5 µg
|
Intramuscular
|
Aluminum (aluminium hydroxide)
|
KRM003
|
NA
|
NA
|
NA
|
NA
|
NA
|
29661808
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
|
NA
|